SubHero Banner
Text

Molnupiravir – An oral treatment for COVID-19 filed for EUA

October 11, 2021 - Merck announced the submission of an application for emergency use authorization (EUA) to the FDA for molnupiravir, an oral treatment for COVID-19.

Download PDF